Thus, it is apparent that copper homeostasis is substantially altered by the expression of mutant SOD1 and that therapeutically modulating copper bioavailability can attenuate ALS-like symptoms in mutant SOD1 mice. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.